Cotellic (cobimetinib) — Medica
Histiocytic neoplasm (Langerhans cell histiocytosis, Erdheim-Chester disease, or Rosai-Dorfman disease)
Initial criteria
- Patient is age ≥ 18 years
- Patient has ONE of the following: Langerhans cell histiocytosis OR Erdheim-Chester disease OR Rosai-Dorfman disease
Approval duration
1 year